BONASO, MARCO
 Distribuzione geografica
Continente #
AS - Asia 146
NA - Nord America 134
EU - Europa 106
SA - Sud America 11
OC - Oceania 2
Totale 399
Nazione #
US - Stati Uniti d'America 130
IT - Italia 49
SG - Singapore 46
CN - Cina 43
FI - Finlandia 25
IN - India 18
JP - Giappone 12
DE - Germania 11
KR - Corea 11
CO - Colombia 10
GB - Regno Unito 10
IR - Iran 7
CA - Canada 3
PK - Pakistan 3
TR - Turchia 3
AT - Austria 2
AU - Australia 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
NL - Olanda 2
PT - Portogallo 2
UA - Ucraina 2
CL - Cile 1
FR - Francia 1
MX - Messico 1
TW - Taiwan 1
Totale 399
Città #
Singapore 39
Santa Clara 31
Boardman 19
Helsinki 18
Kent 15
Florence 14
Munich 11
Hyderabad 7
Mumbai 7
Chicago 6
Jeju City 6
Ogden 6
Pisa 6
Lappeenranta 5
New Malden 5
Quanzhou 5
Santiago de Cali 5
Shanghai 5
Birmingham 4
Fuzhou 4
Milan 4
Pomona 4
Ashburn 3
Denver 3
Kariya 3
Siena 3
Tokyo 3
Ōmura 3
Altopascio 2
Amsterdam 2
Bogotá 2
Dongjak-gu 2
Fiesole 2
Gwangjin-gu 2
Istanbul 2
Lisbon 2
Melbourne 2
Miami 2
New Delhi 2
Oklahoma City 2
Pasto 2
Pensacola 2
Peshawar 2
Raleigh 2
Sheridan 2
Vancouver 2
Vienna 2
West Hempstead 2
Wuhan 2
Beijing 1
Brno 1
City of Westminster 1
Dallas 1
Des Moines 1
Espoo 1
Fremont 1
Guadalajara 1
Gurugram 1
Harlingen 1
Kolkata 1
Livorno 1
Marseille 1
New Taipei City 1
Olomouc 1
Ottawa 1
Pohang 1
Rome 1
Santiago 1
Turin 1
Washington 1
Xiamen 1
Totale 308
Nome #
Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase 75
Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database. 50
Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error. 34
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 24
Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project 23
A regulatory overview of biosimilars across selected countries 21
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 20
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 20
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option 19
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 18
Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World 18
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence 17
Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring 17
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 14
Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x) 13
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database 12
Fat overload syndrome following intravenous lipid emulsion administration as antidote in suspected anesthetic intoxication: insights from a clinical and forensic case experience 9
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison 9
A Cross-National Comparison of Biosimilars Pricing in Argentina, Australia, Brazil, and Italy 5
Communicating Drug Safety 5
Totale 423
Categoria #
all - tutte 2.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024169 0 0 0 0 0 0 23 1 30 18 50 47
2024/2025254 30 35 64 81 44 0 0 0 0 0 0 0
Totale 423